JAFL
MRTX

Jay A. Fishman Ltd’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Jay A. Fishman Ltd’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,000
Closed -$218K – 97
2023
Q3 		$218K Buy
+5,000
New +$218K 0.03% 88
2023
Q1 		– Sell
-5,000
Closed -$227K – 96
2022
Q4 		$227K Buy
+5,000
New +$227K 0.03% 89